The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease

Phosphodiesterase 5 inhibitors are widely used to treat erectile dysfunction and lower urinary tract symptoms with benign prostatic hyperplasia. Recent studies have indicated the renoprotective effects of this class of compounds. Whether renoprotection depends on blood pressure reduction remains con...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Natsumi, Hotta, Yuji, Naiki‐Ito, Aya, Hirano, Kana, Kataoka, Tomoya, Maeda, Yasuhiro, Takahashi, Satoru, Kimura, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503090/
https://www.ncbi.nlm.nih.gov/pubmed/32889777
http://dx.doi.org/10.14814/phy2.14556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503090/
https://www.ncbi.nlm.nih.gov/pubmed/32889777
http://dx.doi.org/10.14814/phy2.14556

Ejemplares similares